Rede Wealth, LLC Bristol Myers Squibb CO Transaction History

Rede Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $20,544 - $24,327	300 Added 5.26%	6,000 $0
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $21,786 - $23,994	-300 Reduced 5.0%	5,700 $439,000
Q1 2022 Apr 18, 2022	SELL	$61.48 - $73.72 $36,273 - $43,494	-590 Reduced 8.95%	6,000 $438,000
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $9,385 - $10,941	-175 Reduced 2.59%	6,590 $411,000
Q3 2021 Oct 08, 2021	BUY	$59.17 - $69.31 $38,223 - $44,774	646 Added 10.56%	6,765 $401,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $40,707 - $45,783	686 Added 12.63%	6,119 $386,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $313,701 - $355,481	5,433 New	5,433 $337,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rede Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Rede Wealth, LLC with notifications on news.